Introduction Today, GLP-1 drugs are most commonly used for diabetes and weight loss, but there is potential for GLP-1 therapies to transform healthcare by offering new solutions for managing chronic conditions
By upgrading to bioactive forms like P5P and significantly increasing key dosages like B12, MSM and Vitamin D, we are delivering a level of cellular support that is rarely seen in a single product
Some research indicates that DSIP may interact with certain drugs
L-carnitine can be found in various foods such as milk, meat and fish
It took me another five or seven more years to basically figure out these products that we have today
One main negative with GLP1 is that, while it does help you lose fat, it doesnt target specific areas of the body